Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Lineage Cell Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
LCTX
NYSE American
2834
www.lineagecell.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Lineage Cell Therapeutics, Inc.
How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets
- Jun 4th, 2026 7:12 am
Promising Penny Stocks To Consider In May 2026
- May 26th, 2026 6:05 am
Lineage Cell Therapeutics Q1 Earnings Call Highlights
- May 15th, 2026 5:10 pm
Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highlights: Strategic Advances and ...
- May 12th, 2026 11:02 pm
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
- May 12th, 2026 3:10 pm
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
- May 12th, 2026 2:01 pm
Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates
- May 11th, 2026 3:15 pm
Guardant Health (GH) Reports Q1 Loss, Beats Revenue Estimates
- May 7th, 2026 3:55 pm
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
- May 5th, 2026 6:00 am
OpRegenĀ® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
- May 4th, 2026 6:00 am
Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration
- Apr 15th, 2026 12:05 pm
Lineage Announces Formation of Scientific Advisory Board
- Apr 13th, 2026 6:00 am
Lineage Cell (LCTX) Launches Its Latest Cell Therapy Program
- Mar 31st, 2026 1:19 am
Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease
- Mar 24th, 2026 6:00 am
Lineage Cell Therapeutics, Inc. Q4 2025 Earnings Call Summary
- Mar 6th, 2026 6:30 am
Lineage Cell Therapeutics Q4 Earnings Call Highlights
- Mar 6th, 2026 3:47 am
Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
- Mar 5th, 2026 3:30 pm
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Mar 5th, 2026 2:01 pm
Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates
- Mar 3rd, 2026 7:15 am
Pacira (PCRX) Lags Q4 Earnings and Revenue Estimates
- Feb 26th, 2026 3:30 pm
Scroll